Page last updated: 2024-10-27

fluconazole and Tetralogy of Fallot

fluconazole has been researched along with Tetralogy of Fallot in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Tetralogy of Fallot: A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.

Research Excerpts

ExcerptRelevanceReference
"Case reports suggest that long-term, high-dose fluconazole treatment for severe fungal infections during pregnancy causes a pattern of birth defects."7.79Use of oral fluconazole during pregnancy and the risk of birth defects. ( Hviid, A; Mølgaard-Nielsen, D; Pasternak, B, 2013)
"Case reports suggest that long-term, high-dose fluconazole treatment for severe fungal infections during pregnancy causes a pattern of birth defects."3.79Use of oral fluconazole during pregnancy and the risk of birth defects. ( Hviid, A; Mølgaard-Nielsen, D; Pasternak, B, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mølgaard-Nielsen, D1
Pasternak, B1
Hviid, A1

Other Studies

1 other study available for fluconazole and Tetralogy of Fallot

ArticleYear
Use of oral fluconazole during pregnancy and the risk of birth defects.
    The New England journal of medicine, 2013, Aug-29, Volume: 369, Issue:9

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Adult; Antifungal Agents; Cohort Studies; Denmark

2013